{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T03:02:13Z","timestamp":1794279733996,"version":"4.9.0"},"reference-count":102,"publisher":"American Chemical Society (ACS)","issue":"15","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32501177"],"award-info":[{"award-number":["32501177"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U22A20328"],"award-info":[{"award-number":["U22A20328"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["W2412035"],"award-info":[{"award-number":["W2412035"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["XDB1060000"],"award-info":[{"award-number":["XDB1060000"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M763423"],"award-info":[{"award-number":["2024M763423"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["BX20250204"],"award-info":[{"award-number":["BX20250204"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["23490712700"],"award-info":[{"award-number":["23490712700"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["23ZR1475000"],"award-info":[{"award-number":["23ZR1475000"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["24430713500"],"award-info":[{"award-number":["24430713500"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["24YF2755800"],"award-info":[{"award-number":["24YF2755800"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012152","name":"National Postdoctoral Program for Innovative Talents","doi-asserted-by":"publisher","award":["BX20250204"],"award-info":[{"award-number":["BX20250204"]}],"id":[{"id":"10.13039\/501100012152","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"Shanghai Oriental Talents Program","doi-asserted-by":"publisher","award":["BJKJ2024046"],"award-info":[{"award-number":["BJKJ2024046"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,4]]},"abstract":"<jats:title>Conspectus<\/jats:title>\n                  <jats:p>The emerging advance of targeted protein degradation (TPD) technology offers a novel option for protein modulation, ensuring a more durable and precise therapeutic impact for cancer management. While promising, complete degradation of the proteins of interest (POIs) in both pathological and normal tissues may cause severe side effects. Furthermore, insufficient accumulation of the protein degraders at the target tissues also limits the clinical translation of TPD. It remains an unmet need to achieve spatiotemporally tunable degradation of the POI at the tumor lesion. In recent years, our group has extensively exploited the potential of the stimuli-activatable TPD technology for precise cancer therapy. The stimuli-activatable protein degraders were rationally designed for achieving tumor-specific enrichment in vivo to maximize their therapeutic effects while minimizing the side effects. Several kinds of stimuli-labile prodrugs of the proteolysis targeting chimeras (PROTACs) were rationally designed for restoring their protein degradation functions with the endogenous or exogenous stimulus of tumor while remaining \u201csilent\u201d elsewhere, resulting in precise therapies and reduced side effects. Leveraging the advantages of nanomedicine delivery systems, several kinds of tumor acidity and enzymatic-activatable nanodegraders were developed to achieve tumor-targeted protein degrader distribution and POI degradation. In particular, photothermally activatable protein degraders were developed to perform spatiotemporally controllable degradation of various POIs.<\/jats:p>\n                  <jats:p>In this Account, we systematically summarize recent advances from our group regarding the rational design of stimuli-activatable protein degraders, and strategically outline the \u201cwhen and how\u201d of integrating these degraders with nanomedicine platforms to tailor precise cancer therapy. We discuss the crucial role of the tumor microenvironment-responsive moieties for stimuli-triggered degradation of both intracellular and membrane POIs, highlighting the distinct design rationale for their respective prodrugs. Furthermore, we summarize our advances of strategic integration of the TPD technology with nanomedicine to augment the therapeutic outcomes of phototherapy, radiotherapy, chemotherapy, and immunotherapy of solid tumors. It is envisaged that the tumor microenvironment-activatable protein degradation approaches will achieve tumor-specific protein degradation and precision therapy, thereby facilitating the clinical application of TPD. By outlining optimized design strategies and future challenges, this Account aims to serve as a roadmap for researchers seeking to develop next-generation activatable TPD technologies that are modular, functionally versatile, and translatable.<\/jats:p>","DOI":"10.1021\/acs.accounts.6c00270","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T18:09:19Z","timestamp":1784311759000},"page":"2348-2364","source":"Crossref","is-referenced-by-count":1,"title":["Molecular Engineering of Stimuli-Activatable Protein\nDegraders for Precise Cancer Therapy"],"prefix":"10.1021","volume":"59","author":[{"given":"Jing","family":"Gao","sequence":"first","affiliation":[{"name":"Shanghai Institute of Materia Medica, Chinese Academy of Sciences , , ,","place":["Shanghai, China, 201203"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lai","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Materia Medica, Chinese Academy of Sciences , , ,","place":["Shanghai, China, 201203"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Hou","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Materia Medica, Chinese Academy of Sciences , , ,","place":["Shanghai, China, 201203"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijing","family":"Dang","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Materia Medica, Chinese Academy of Sciences , , ,","place":["Shanghai, China, 201203"]},{"name":"East China Normal University , , ,","place":["Shanghai, China, 200241"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiling","family":"Zhou","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Materia Medica, Chinese Academy of Sciences , , ,","place":["Shanghai, China, 201203"]},{"name":"East China Normal University , , ,","place":["Shanghai, China, 200241"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4391-2507","authenticated-orcid":true,"given":"Zhiai","family":"Xu","sequence":"additional","affiliation":[{"name":"East China Normal University , , ,","place":["Shanghai, China, 200241"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3398-0880","authenticated-orcid":true,"given":"Haijun","family":"Yu","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Materia Medica, Chinese Academy of Sciences , , ,","place":["Shanghai, China, 201203"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"issue":"1","key":"2026080408070984900_cit1","doi-asserted-by":"publisher","first-page":"4318","DOI":"10.1038\/s41467-022-32050-4","article-title":"Engineered\nbioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein\ndegradation and precise cancer therapy","volume":"13","author":"Gao","year":"2022","journal-title":"Nat.\nCommun."},{"issue":"1","key":"2026080408070984900_cit2","doi-asserted-by":"publisher","first-page":"6608","DOI":"10.1038\/s41467-024-50735-w","article-title":"A region-confined PROTAC\nnanoplatform for spatiotemporally tunable\nprotein degradation and enhanced cancer therapy","volume":"15","author":"Gao","year":"2024","journal-title":"Nat. Commun."},{"issue":"27","key":"2026080408070984900_cit3","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202504233","article-title":"De novo design of structure-tunable multivalent targeting chimeras\nfor tumor-targeted PD-L1 degradation and potentiated cancer immunotherapy","volume":"64","author":"Zhou","year":"2025","journal-title":"Angew. Chem., Int. Ed."},{"issue":"46","key":"2026080408070984900_cit4","doi-asserted-by":"publisher","first-page":"eadq3940","DOI":"10.1126\/sciadv.adq3940","article-title":"Tumor-specific\ndelivery of clickable inhibitor for PD-L1 degradation and mitigating\nresistance of radioimmunotherapy","volume":"10","author":"Hou","year":"2024","journal-title":"Sci. Adv."},{"issue":"2","key":"2026080408070984900_cit5","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1021\/jacs.5c16311","article-title":"In situ\ntransformable photothermal targeting chimeras for spatiotemporally\ncontrollable protein degradation and combination immunotherapy for\ncancer","volume":"148","author":"Dang","year":"2026","journal-title":"J. Am. Chem. Soc."},{"issue":"3","key":"2026080408070984900_cit6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC\ntargeted protein degraders:\nthe past is prologue","volume":"21","author":"Be\u0301ke\u0301s","year":"2022","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"10","key":"2026080408070984900_cit7","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s41568-021-00365-x","article-title":"Advancing\ntargeted protein degradation\nfor cancer therapy","volume":"21","author":"Dale","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"2026080408070984900_cit8","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/s41573-019-0047-y","article-title":"Targeted protein\ndegradation: expanding the toolbox","volume":"18","author":"Schapira","year":"2019","journal-title":"Nat. Rev.\nDrug Discovery"},{"issue":"1","key":"2026080408070984900_cit9","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.cell.2019.11.031","article-title":"Proteolysis-targeting\nchimeras as therapeutics and\ntools for biological discovery","volume":"181","author":"Burslem","year":"2020","journal-title":"Cell"},{"issue":"9","key":"2026080408070984900_cit10","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s41580-024-00729-9","article-title":"Targeted protein\ndegradation: from mechanisms to clinic","volume":"25","author":"Tsai","year":"2024","journal-title":"Nat.\nRev. Mol. Cell Biol."},{"issue":"15","key":"2026080408070984900_cit11","doi-asserted-by":"publisher","first-page":"8554","DOI":"10.1073\/pnas.141230798","article-title":"Protacs: Chimeric molecules that\ntarget proteins to\nthe Skp1-Cullin-F box complex for ubiquitination and degradation","volume":"98","author":"Sakamoto","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7820","key":"2026080408070984900_cit12","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41586-020-2545-9","article-title":"Lysosome-targeting chimaeras for\ndegradation of extracellular\nproteins","volume":"584","author":"Banik","year":"2020","journal-title":"Nature"},{"issue":"21","key":"2026080408070984900_cit13","doi-asserted-by":"publisher","first-page":"8832","DOI":"10.1039\/D2CS00624C","article-title":"Emerging degrader technologies\nengaging lysosomal pathways","volume":"51","author":"Ding","year":"2022","journal-title":"Chem. Soc. Rev."},{"issue":"8","key":"2026080408070984900_cit14","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/nrc.2017.36","article-title":"Drugging the \u2019undruggable\u2019\ncancer targets","volume":"17","author":"Dang","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"2026080408070984900_cit15","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.scib.2023.04.028","article-title":"Stimuli-activatable\nPROTACs for precise protein degradation\nand cancer therapy","volume":"68","author":"Gao","year":"2023","journal-title":"Sci. Bull."},{"key":"2026080408070984900_cit16","doi-asserted-by":"publisher","first-page":"115809","DOI":"10.1016\/j.addr.2026.115809","article-title":"Advances in targeted\nprotein degradation and delivery systems","volume":"231","author":"Xu","year":"2026","journal-title":"Adv.\nDrug Delivery Rev."},{"key":"2026080408070984900_cit17","doi-asserted-by":"publisher","DOI":"10.1002\/ange.202306824","article-title":"Stimuli-responsive\nPROTACs for controlled protein degradation","volume":"62","author":"An","year":"2023","journal-title":"Angew. Chem., Int. Ed."},{"issue":"8","key":"2026080408070984900_cit18","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1021\/acs.accounts.5c00003","article-title":"Strategies for precise modulation\nof protein degradation","volume":"58","author":"He","year":"2025","journal-title":"Acc. Chem. Res."},{"key":"2026080408070984900_cit19","doi-asserted-by":"publisher","first-page":"115808","DOI":"10.1016\/j.addr.2026.115808","article-title":"Stimuli-activatable protein degraders for targeted\ncancer therapy: from prodrug design to nanoplatform applications","volume":"232","author":"Jiang","year":"2026","journal-title":"Adv. Drug Delivery Rev."},{"key":"2026080408070984900_cit20","doi-asserted-by":"publisher","DOI":"10.1021\/polymscitech.5c00122","article-title":"Engineering polymeric\nnano-PROTAC for targeted protein degradation and cancer therapy","author":"Saeed","year":"2026","journal-title":"Polym. Sci. Technol."},{"issue":"12","key":"2026080408070984900_cit21","doi-asserted-by":"publisher","first-page":"1907210","DOI":"10.1002\/adma.201907210","article-title":"Engineering stimuli-activatable boolean\nlogic prodrug nanoparticles for combination cancer immunotherapy","volume":"32","author":"Hou","year":"2020","journal-title":"Adv. Mater."},{"issue":"23","key":"2026080408070984900_cit22","doi-asserted-by":"publisher","first-page":"2002365","DOI":"10.1002\/advs.202002365","article-title":"Engineering prodrug\nnanomedicine for cancer immunotherapy","volume":"7","author":"Yang","year":"2020","journal-title":"Adv.\nSci."},{"issue":"2","key":"2026080408070984900_cit23","doi-asserted-by":"publisher","first-page":"e12376","DOI":"10.1002\/adma.202412376","article-title":"A hypoxia-activatable prodrug for targeted combination therapy of\nhepatoma","volume":"38","author":"Wang","year":"2026","journal-title":"Adv. Mater."},{"key":"2026080408070984900_cit24","doi-asserted-by":"publisher","first-page":"101661","DOI":"10.1016\/j.nantod.2022.101661","article-title":"In-situ clickable prodrug nanoplatform\nlocally activates T lymphocytes to\npotentiate cancer immunotherapy","volume":"47","author":"Hou","year":"2022","journal-title":"Nano Today"},{"issue":"8","key":"2026080408070984900_cit25","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1021\/acscentsci.5c00875","article-title":"Radiotherapy-activated\nprodrug: past,\npresent and beyond","volume":"11","author":"Wang","year":"2025","journal-title":"ACS Cent. Sci."},{"issue":"40","key":"2026080408070984900_cit26","doi-asserted-by":"publisher","first-page":"1902960","DOI":"10.1002\/adma.201902960","article-title":"Self-amplified\ndrug delivery with light-inducible nanocargoes to enhance cancer immunotherapy","volume":"31","author":"Feng","year":"2019","journal-title":"Adv. Mater."},{"issue":"26","key":"2026080408070984900_cit27","doi-asserted-by":"publisher","first-page":"22412","DOI":"10.1021\/jacs.5c00124","article-title":"Engineering\nof sono-activatable immunogels for immunometabolism disorder normalization\ntherapy of breast cancer","volume":"147","author":"Guo","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"12","key":"2026080408070984900_cit28","doi-asserted-by":"publisher","first-page":"108332","DOI":"10.1016\/j.cclet.2023.108332","article-title":"Dual stimuli-activatable versatile nanoplatform for photodynamic\ntherapy and chemotherapy of triple-negative breast cancer","volume":"34","author":"Xu","year":"2023","journal-title":"Chin. Chem. Lett."},{"issue":"9","key":"2026080408070984900_cit29","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.1016\/j.apsb.2022.05.016","article-title":"Dual-targeting prodrug\nnanotheranostics for NIR-II fluorescence imaging-guided photo-immunotherapy\nof glioblastoma","volume":"12","author":"Li","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"5","key":"2026080408070984900_cit30","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1021\/acs.jmedchem.0c01846","article-title":"Antibody-mediated delivery of chimeric BRD4\ndegraders. Part 2: improvement of in vitro antiproliferation\nactivity and in vivo antitumor efficacy","volume":"64","author":"Dragovich","year":"2021","journal-title":"J. Med. Chem."},{"issue":"19","key":"2026080408070984900_cit31","doi-asserted-by":"publisher","first-page":"7380","DOI":"10.1021\/jacs.1c00451","article-title":"Cancer selective target\ndegradation by folate-caged PROTACs","volume":"143","author":"Liu","year":"2021","journal-title":"J. Am.\nChem. Soc."},{"issue":"43","key":"2026080408070984900_cit32","doi-asserted-by":"publisher","first-page":"23299","DOI":"10.1002\/anie.202107347","article-title":"Aptamer-PROTAC\nconjugates (APCs) for tumor-specific targeting in breast cancer","volume":"60","author":"He","year":"2021","journal-title":"Angew. Chem., Int. Ed."},{"issue":"8","key":"2026080408070984900_cit33","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1038\/s41401-024-01266-z","article-title":"Tumor-targeted PROTAC prodrug nanoplatform\nenables precise protein\ndegradation and combination cancer therapy","volume":"45","author":"Zou","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"issue":"45","key":"2026080408070984900_cit34","doi-asserted-by":"publisher","first-page":"5904","DOI":"10.1038\/onc.2008.271","article-title":"The tumor\nmicroenvironment and its role in promoting tumor growth","volume":"27","author":"Whiteside","year":"2008","journal-title":"Oncogene"},{"issue":"6","key":"2026080408070984900_cit35","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ccr.2005.05.024","article-title":"Therapeutic\ntargeting of the tumor microenvironment","volume":"7","author":"Joyce","year":"2005","journal-title":"Cancer\nCell"},{"issue":"1","key":"2026080408070984900_cit36","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1038\/s41467-023-39035-x","article-title":"Nanovesicles loaded\nwith a TGF-\u03b2 receptor 1 inhibitor overcome\nimmune resistance to potentiate cancer immunotherapy","volume":"14","author":"Zhou","year":"2023","journal-title":"Nat. Commun."},{"key":"2026080408070984900_cit37","doi-asserted-by":"publisher","first-page":"101025","DOI":"10.1016\/j.nantod.2020.101025","article-title":"Overcoming immune resistance by sequential prodrug\nnanovesicles for\npromoting chemoimmunotherapy of cancer","volume":"36","author":"Zhou","year":"2021","journal-title":"Nano\nToday"},{"key":"2026080408070984900_cit38","doi-asserted-by":"publisher","first-page":"115620","DOI":"10.1016\/j.addr.2025.115620","article-title":"Smart\ndrug delivery platforms reprogramming cancer immune cycle to mitigate\nimmune resistance of pancreatic tumors","volume":"224","author":"Zhang","year":"2025","journal-title":"Adv.\nDrug Delivery Rev."},{"issue":"5930","key":"2026080408070984900_cit39","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the\nWarburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"issue":"5","key":"2026080408070984900_cit40","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1158\/0008-5472.CAN-12-2796","article-title":"Acidity generated by\nthe tumor microenvironment drives local invasion","volume":"73","author":"Estrella","year":"2013","journal-title":"Cancer Res."},{"key":"2026080408070984900_cit41","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejps.2016.12.011","article-title":"Hydrazone linkages\nin pH responsive\ndrug delivery systems","volume":"99","author":"Sonawane","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"issue":"5","key":"2026080408070984900_cit42","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1021\/cr60291a004","article-title":"Mechanism and catalysis\nfor hydrolysis of acetals, ketals, and ortho\nesters","volume":"74","author":"Cordes","year":"1974","journal-title":"Chem. Rev."},{"issue":"6","key":"2026080408070984900_cit43","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1039\/c2cs15305j","article-title":"Dynamic imine chemistry","volume":"41","author":"Belowich","year":"2012","journal-title":"Chem.\nSoc. Rev."},{"issue":"4","key":"2026080408070984900_cit44","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s00214-002-0403-5","article-title":"Aconityl-derived polymers for biomedical\napplications. Modeling study of cis-trans isomerisation","volume":"109","author":"Zloh","year":"2003","journal-title":"Theor. Chem. Acc."},{"key":"2026080408070984900_cit45","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/B978-0-323-91663-9.00015-1","article-title":"Polymer-drug conjugation\nusing ester and ortho-ester bond: Mechanism, protocols, and applications","volume-title":"Polymer-Drug Conjugates","author":"Chaudhary","year":"2023"},{"issue":"2","key":"2026080408070984900_cit46","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nmat3819","article-title":"A nanoparticle-based\nstrategy for the imaging of a\nbroad range of tumours by nonlinear amplification of microenvironment\nsignals","volume":"13","author":"Wang","year":"2014","journal-title":"Nat. Mater."},{"issue":"10","key":"2026080408070984900_cit47","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/nrc1949","article-title":"Multifunctional\nenzymes in cancer","volume":"6","author":"Mohamed","year":"2006","journal-title":"Nat. Rev. Cancer"},{"issue":"43","key":"2026080408070984900_cit48","doi-asserted-by":"publisher","first-page":"2102668","DOI":"10.1002\/adma.202102668","article-title":"Engineering chameleon\nprodrug nanovesicles to increase antigen presentation and inhibit\nPD-L1 expression for circumventing immune resistance of cancer","volume":"33","author":"Zhou","year":"2021","journal-title":"Adv. Mater."},{"issue":"47","key":"2026080408070984900_cit49","doi-asserted-by":"publisher","first-page":"2305798","DOI":"10.1002\/adma.202305798","article-title":"Self-adaptive nanoregulator to mitigate dynamic immune evasion of\npancreatic cancer","volume":"35","author":"Pan","year":"2023","journal-title":"Adv. Mater."},{"issue":"2","key":"2026080408070984900_cit50","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3892\/ijo.2012.1754","article-title":"Cathepsin\nB-cleavable doxorubicin\nprodrugs for targeted cancer therapy","volume":"42","author":"Zhong","year":"2013","journal-title":"Int. J.\nOncol."},{"key":"2026080408070984900_cit51","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.semradonc.2004.04.001","article-title":"Oxidative stress, redox, and the tumor microenvironment","volume":"14","author":"Cook","year":"2004","journal-title":"Semin. Radiat. Oncol."},{"issue":"7","key":"2026080408070984900_cit52","doi-asserted-by":"publisher","first-page":"5071","DOI":"10.1021\/cr300358b","article-title":"Disulfide-cleavage-triggered\nchemosensors\nand their biological applications","volume":"113","author":"Lee","year":"2013","journal-title":"Chem. Rev."},{"issue":"13","key":"2026080408070984900_cit53","doi-asserted-by":"publisher","first-page":"7740","DOI":"10.1039\/C9RA10539E","article-title":"The role of\nreactive oxygen species in tumor treatment","volume":"10","author":"Jia","year":"2020","journal-title":"RSC Adv."},{"issue":"9","key":"2026080408070984900_cit54","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/s41557-019-0314-x","article-title":"The mechanisms of boronate ester\nformation and fluorescent turn-on in ortho-aminomethylphenylboronic\nacids","volume":"11","author":"Sun","year":"2019","journal-title":"Nat. Chem."},{"issue":"4","key":"2026080408070984900_cit55","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1021\/acsmacrolett.5c00842","article-title":"Thioketal-based polymers\nfor biomedical applications:\nstructure design, properties, and perspectives","volume":"15","author":"Zhang","year":"2026","journal-title":"ACS Macro. Lett."},{"key":"2026080408070984900_cit56","doi-asserted-by":"publisher","first-page":"113707","DOI":"10.1016\/j.biopha.2022.113707","article-title":"Insights\ninto stimuli-responsive diselenide bonds utilized in drug delivery\nsystems for cancer therapy","volume":"155","author":"Shi","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"2026080408070984900_cit57","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S1535-6108(03)00194-6","article-title":"The hypoxic response\nof tumors is dependent on their microenvironment","volume":"4","author":"Blouw","year":"2003","journal-title":"Cancer Cell"},{"issue":"6","key":"2026080408070984900_cit58","doi-asserted-by":"publisher","first-page":"5057","DOI":"10.1021\/acs.jmedchem.1c02221","article-title":"Rational\ndesign for nitroreductase (NTR)-responsive proteolysis targeting chimeras\n(PROTACs) selectively targeting tumor tissues","volume":"65","author":"Shi","year":"2022","journal-title":"J. Med. Chem."},{"issue":"2","key":"2026080408070984900_cit59","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1021\/acs.analchem.8b03492","article-title":"Azoreductase-responsive\nnanoprobe for hypoxia-induced mitophagy imaging","volume":"91","author":"Ma","year":"2019","journal-title":"Anal. Chem."},{"issue":"5","key":"2026080408070984900_cit60","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/(SICI)1521-1878(200005)22:5&lt;442::AID-BIES6&gt;3.0.CO;2-Q","article-title":"Ubiquitin-mediated\nproteolysis: biological\nregulation via destruction","volume":"22","author":"Ciechanover","year":"2000","journal-title":"BioEssays"},{"issue":"1","key":"2026080408070984900_cit61","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1146\/annurev.biochem.70.1.503","article-title":"Mechanisms\nunderlying ubiquitination","volume":"70","author":"Pickart","year":"2001","journal-title":"Annu. Rev. Biochem."},{"issue":"1","key":"2026080408070984900_cit62","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41392-024-02004-x","article-title":"Targeted protein degradation:\nadvances in drug discovery and clinical practice","volume":"9","author":"Zhong","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"2","key":"2026080408070984900_cit63","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance\nto cancer therapies","volume":"15","author":"Dagogo-Jack","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"749","key":"2026080408070984900_cit64","doi-asserted-by":"publisher","first-page":"eabn2707","DOI":"10.1126\/scisignal.abn2707","article-title":"The drug efflux pump MDR1 promotes intrinsic and acquired resistance\nto PROTACs in cancer cells","volume":"15","author":"Kurimchak","year":"2022","journal-title":"Sci. Signaling"},{"issue":"14","key":"2026080408070984900_cit65","doi-asserted-by":"publisher","first-page":"10982","DOI":"10.1021\/acsnano.5c20138","article-title":"Coassembled prodrug nanoparticles mitigating\nthe acquired resistance\nto protein degradation therapy","volume":"20","author":"Gao","year":"2026","journal-title":"ACS Nano"},{"issue":"23","key":"2026080408070984900_cit66","doi-asserted-by":"publisher","first-page":"2314132","DOI":"10.1002\/adma.202314132","article-title":"PROTAC prodrug-integrated nanosensitizer for potentiating radiation\ntherapy of cancer","volume":"36","author":"Zhang","year":"2024","journal-title":"Adv. Mater."},{"issue":"13","key":"2026080408070984900_cit67","doi-asserted-by":"publisher","first-page":"2411869","DOI":"10.1002\/adma.202411869","article-title":"Self-oxygenating\nPROTAC microneedle for spatiotemporally-confined\nprotein degradation and enhanced glioblastoma therapy","volume":"37","author":"Jiang","year":"2025","journal-title":"Adv. Mater."},{"issue":"6220","key":"2026080408070984900_cit68","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Tissue-based map of the human proteome","volume":"347","author":"Uhle\u0301n","year":"2015","journal-title":"Science"},{"issue":"11","key":"2026080408070984900_cit69","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.tips.2023.08.013","article-title":"Targeted degradation\nof extracellular secreted and membrane proteins","volume":"44","author":"Chen","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"2026080408070984900_cit70","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41573-023-00833-z","article-title":"Extracellular targeted\nprotein degradation: an emerging modality\nfor drug discovery","volume":"23","author":"Wells","year":"2024","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"9","key":"2026080408070984900_cit71","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/s41589-021-00770-1","article-title":"LYTACs\nthat engage the asialoglycoprotein receptor\nfor targeted protein degradation","volume":"17","author":"Ahn","year":"2021","journal-title":"Nat. Chem.\nBiol."},{"issue":"8051","key":"2026080408070984900_cit72","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41586-024-07947-3","article-title":"Transferrin receptor\ntargeting chimeras for membrane protein degradation","volume":"638","author":"Zhang","year":"2025","journal-title":"Nature"},{"issue":"2","key":"2026080408070984900_cit73","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1021\/jacs.0c10008","article-title":"Development\nof antibody-based PROTACs for the degradation of the cell-surface\nimmune checkpoint protein PD-L1","volume":"143","author":"Cotton","year":"2021","journal-title":"J. Am. Chem.\nSoc."},{"issue":"7930","key":"2026080408070984900_cit74","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41586-022-05235-6","article-title":"Antibody targeting of E3 ubiquitin ligases for receptor degradation","volume":"610","author":"Marei","year":"2022","journal-title":"Nature"},{"issue":"40","key":"2026080408070984900_cit75","doi-asserted-by":"publisher","first-page":"16377","DOI":"10.1021\/jacs.1c08521","article-title":"Covalently engineered\nnanobody chimeras for targeted membrane protein degradation","volume":"143","author":"Zhang","year":"2021","journal-title":"J. Am. Chem. Soc."},{"issue":"20","key":"2026080408070984900_cit76","doi-asserted-by":"publisher","first-page":"2400109","DOI":"10.1002\/adhm.202400109","article-title":"Folate-PEG-PROTAC micelles\nfor enhancing\ntumor-specific targeting proteolysis in vivo","volume":"13","author":"Ma","year":"2024","journal-title":"Adv. Healthcare Mater."},{"issue":"29","key":"2026080408070984900_cit77","doi-asserted-by":"publisher","first-page":"2504253","DOI":"10.1002\/adma.202504253","article-title":"Biomimetic hybrid PROTAC\nnanovesicles block multiple DNA repair pathways to overcome Temozolomide\nresistance against orthotopic glioblastoma","volume":"37","author":"Xu","year":"2025","journal-title":"Adv. Mater."},{"issue":"36","key":"2026080408070984900_cit78","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202501384","article-title":"Remodeling\nthe physicochemical and pharmacokinetic\nproperties of PROTAC via lipid nanodisks for cancer therapy","volume":"12","author":"Pan","year":"2025","journal-title":"Adv. Sci."},{"issue":"1","key":"2026080408070984900_cit79","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1038\/s41467-021-23194-w","article-title":"Semiconducting polymer nano-PROTACs\nfor activatable photo-immunometabolic cancer therapy","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."},{"issue":"8","key":"2026080408070984900_cit80","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202114957","article-title":"Smart nano-PROTACs\nreprogram tumor microenvironment for activatable photo-metabolic cancer\nimmunotherapy","volume":"61","author":"Zhang","year":"2022","journal-title":"Angew. Chem., Int. Ed."},{"issue":"38","key":"2026080408070984900_cit81","doi-asserted-by":"publisher","first-page":"2405475","DOI":"10.1002\/adma.202405475","article-title":"Light-triggered PROTAC nanoassemblies for photodynamic\nIDO proteolysis in cancer immunotherapy","volume":"36","author":"Choi","year":"2024","journal-title":"Adv.\nMater."},{"issue":"26","key":"2026080408070984900_cit82","doi-asserted-by":"publisher","first-page":"2300871","DOI":"10.1002\/adhm.202300871","article-title":"Exploiting\ncancer vulnerabilities by blocking of the DHODH and GPX4 pathways:\na multifunctional Bodipy\/PROTAC nanoplatform for the efficient synergistic\nferroptosis therapy","volume":"12","author":"Yao","year":"2023","journal-title":"Adv. Healthcare Mater."},{"issue":"6","key":"2026080408070984900_cit83","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1021\/acs.molpharmaceut.5c00219","article-title":"Self-assembled peptide PROTAC prodrugs\ntargeting FOXM1 for cancer\ntherapy","volume":"22","author":"Zeng","year":"2025","journal-title":"Mol. Pharmaceutics"},{"key":"2026080408070984900_cit84","doi-asserted-by":"publisher","first-page":"122038","DOI":"10.1016\/j.biomaterials.2023.122038","article-title":"In situ albumin-binding and esterase-specifically cleaved BRD4-degrading\nPROTAC for targeted cancer therapy","volume":"295","author":"Cho","year":"2023","journal-title":"Biomaterials"},{"issue":"30","key":"2026080408070984900_cit85","doi-asserted-by":"publisher","first-page":"16642","DOI":"10.1021\/jacs.3c04109","article-title":"Self-assembled\nnano-PROTAC enables near-infrared photodynamic proteolysis for cancer\ntherapy","volume":"145","author":"Wang","year":"2023","journal-title":"J. Am. Chem. Soc."},{"issue":"16","key":"2026080408070984900_cit86","doi-asserted-by":"publisher","first-page":"4858","DOI":"10.1021\/acs.nanolett.4c00201","article-title":"Liposomal STAT3-degrading PROTAC\nprodrugs promote anti-hepatocellular carcinoma immunity via chemically\nreprogramming cancer stem cells","volume":"24","author":"Wang","year":"2024","journal-title":"Nano Lett."},{"issue":"28","key":"2026080408070984900_cit87","doi-asserted-by":"publisher","first-page":"8741","DOI":"10.1021\/acs.nanolett.4c02287","article-title":"Ultrasound-activated\nPROTAC prodrugs overcome immunosuppression to actuate efficient deep-tissue\nsono-immunotherapy in orthotopic pancreatic tumor mouse models","volume":"24","author":"Liu","year":"2024","journal-title":"Nano Lett."},{"issue":"21","key":"2026080408070984900_cit88","doi-asserted-by":"publisher","first-page":"e21641","DOI":"10.1002\/adfm.202521641","article-title":"CDT prodrug therapy\nwith cascade-activated\nPROTAC delivery platform for mutually reinforced ferroptosis and apoptosis-based\ntherapy","volume":"36","author":"Xu","year":"2026","journal-title":"Adv. Funct. Mater."},{"key":"2026080408070984900_cit89","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/s12951-026-04266-9","article-title":"Dual tumor microenvironment-responsive\nalbumin nanoplatform integrates conditional PROTAC activation with\nstarvation and ferroptosis for synergistic cancer therapy","volume":"24","author":"Lin","year":"2026","journal-title":"J. Nanobiotechnol."},{"issue":"9","key":"2026080408070984900_cit90","doi-asserted-by":"publisher","first-page":"4945","DOI":"10.1016\/j.apsb.2025.07.020","article-title":"Photodynamic\nenhancement of PROTAC prodrug activation in hypoxic\ntumors","volume":"15","author":"Fu","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"issue":"13","key":"2026080408070984900_cit91","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1039\/D3TB03046F","article-title":"Radiation\nresponsive PROTAC nanoparticles for tumor-specific proteolysis\nenhanced radiotherapy","volume":"12","author":"Xu","year":"2024","journal-title":"J. Mater. Chem. B"},{"issue":"1","key":"2026080408070984900_cit92","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41392-024-01983-1","article-title":"Sequential responsive nano-PROTACs for precise\nintracellular\ndelivery and enhanced degradation efficacy in colorectal cancer therapy","volume":"9","author":"Yang","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"21","key":"2026080408070984900_cit93","doi-asserted-by":"publisher","first-page":"22665","DOI":"10.1021\/acs.jmedchem.5c01632","article-title":"Rational design of\nPROTAC degraders and their spatiotemporal controlled delivery for\nenhanced tumor penetration and PD-L1 protein degradation","volume":"68","author":"Qi","year":"2025","journal-title":"J. Med. Chem."},{"issue":"6776","key":"2026080408070984900_cit94","doi-asserted-by":"publisher","first-page":"eadx5094","DOI":"10.1126\/science.adx5094","article-title":"Targeted\nprotein degradation in the\ntransmembrane and extracellular space","volume":"390","author":"Zhu","year":"2025","journal-title":"Science"},{"issue":"12","key":"2026080408070984900_cit95","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.3390\/pharmaceutics14122728","article-title":"PLGA-based\nnanomedicine: history of advancement\nand development in clinical applications of multiple diseases","volume":"14","author":"Alsaab","year":"2022","journal-title":"Pharmaceutics"},{"key":"2026080408070984900_cit96","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jconrel.2014.03.013","article-title":"A clinical\nupdate of using albumin as a drug vehicle-A commentary","volume":"190","author":"Kratz","year":"2014","journal-title":"J. Controlled Release"},{"key":"2026080408070984900_cit97","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.jconrel.2019.12.023","article-title":"The role of liposomes\nin clinical\nnanomedicine development. What now? Now what?","volume":"318","author":"Crommelin","year":"2020","journal-title":"J. Controlled Release"},{"issue":"12","key":"2026080408070984900_cit98","doi-asserted-by":"publisher","first-page":"12369","DOI":"10.1021\/acs.jmedchem.5c00826","article-title":"Current and emerging prodrug strategies","volume":"68","author":"Brown","year":"2025","journal-title":"J.\nMed. Chem."},{"issue":"1","key":"2026080408070984900_cit99","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s11671-023-03950-1","article-title":"Prodrug-based nanomedicines\nfor rheumatoid arthritis","volume":"19","author":"Li","year":"2024","journal-title":"Discover Nano"},{"issue":"3","key":"2026080408070984900_cit100","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00044-022-02859-1","article-title":"An insight into\nprodrug strategy\nfor the treatment of Alzheimer\u2019s disease","volume":"31","author":"Bhilare","year":"2022","journal-title":"Med. Chem. Res."},{"key":"2026080408070984900_cit101","doi-asserted-by":"publisher","first-page":"115876","DOI":"10.1016\/j.addr.2026.115876","article-title":"Engineering brain-penetrant PROTACs: Bridging molecular\ndesign and\nCNS delivery","volume":"234","author":"Li","year":"2026","journal-title":"Adv. Drug Delivery Rev."},{"issue":"23","key":"2026080408070984900_cit102","doi-asserted-by":"publisher","first-page":"24287","DOI":"10.1021\/jacs.6c05275","article-title":"Glycoengineered\nhost-guest nanoparticles potentiate\nAlzheimer\u2019s disease therapy via lesion-specific modulation\nof Tau pathology","volume":"148","author":"Lai","year":"2026","journal-title":"J. Am. Chem. Soc."}],"container-title":["Accounts of Chemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.accounts.6c00270","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/achre4\/article-pdf\/59\/15\/2348\/66014204\/acs.accounts.6c00270.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/achre4\/article-pdf\/59\/15\/2348\/66014204\/acs.accounts.6c00270.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T12:12:42Z","timestamp":1785845562000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/achre4\/article\/59\/15\/2348\/5214727\/Molecular-Engineering-of-Stimuli-Activatable"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":102,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2026,7,17]]},"published-print":{"date-parts":[[2026,8,4]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.accounts.6c00270","relation":{},"ISSN":["0001-4842","1520-4898"],"issn-type":[{"value":"0001-4842","type":"print"},{"value":"1520-4898","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]}}}